Weight Loss Sale

Life Extension Update

Soy offers hope in treatment-resistant prostate cancer

Soy offers hope in treatment-resistant prostate cancer

Friday, December 16, 2011. The results of a pilot study published in the November, 2011 issue of the Southern Medical Journal suggest a benefit for soy in men whose prostate cancer failed to respond to radiation or surgery.

The success of prostate cancer therapy is evaluated by measuring a protein known as serum prostate specific antigen (PSA). A rise in PSA following radiation or surgery for prostate cancer indicates treatment failure. An option for these patients is androgen deprivation therapy which reduces testosterone (a hormone that may increase the growth of prostate cancer); however, the treatment has significant side effects and is not effective for all who use it.

Monika Joshi, MD and her colleagues at Pennsylvania State University enrolled ten men with treatment-resistant prostate cancer that had not metastasized, and assigned them to three servings of soy per day for two years, during which PSA levels were monitored. After 24 months, half of the men showed a response to soy with temporary or permanently declining PSA levels or stable PSA levels. Of three subjects who were being treated with androgen deprivation therapy and continued to have rising PSA levels, one responded to soy, while four of the remaining seven showed favorable responses. The researchers remark that soy may reduce PSA via a reduction in the expression of the androgen receptor and other mechanisms.

"Our findings are fairly congruent with what has been described in the literature on the use of this modality in prostate cancer," the authors write. "We also show that soy can provide benefit in castration-resistant prostate cancer. Our clinical experience suggests that soy supplementation using commercially available soy products can have durable beneficial effects on PSA levels and PSA kinetics in some men with prostate cancer."

"The results from Pennsylvania State University appear consistent with a considerable amount of published research showing that soy may help to prevent prostate cancer and may be useful in its treatment," noted oncologist Omer Kucuk, MD, who is Georgia Cancer Coalition's distinguished cancer scholar and chief of genitourinary medical oncology at Emory University's Winship Cancer Institute. "For men unresponsive to surgery and radiation for prostate cancer, it is critically important to find androgen deprivation therapy alternatives, such as soy as a dietary intervention. While this study is small, it's important because it takes place in real-life conditions in a clinical setting."

shadow
What's Hot Highlight

Soy peptide aids in blocking metastasis

What's Hot

An article published online on September 10, 2011 in the journal Cancer Letters describes the discovery of Elvira Gonzalez de Mejia and Vermont P. Dia of the University of Illinois in Urbana of a benefit for lunasin, a peptide that occurs in soy, in preventing the spread of colon cancer to the liver, the predominant site of metastasis for this type of cancer. "When lunasin was used in combination with the chemotherapy drug oxaliplatin, we saw a sixfold reduction in the number of new tumor sites," revealed Dr de Mejia, who is an associate professor of food chemistry and food toxicology at UI.

The current study utilized mice bred to develop colon cancer that metastasizes to the liver. The researchers divided the animals to receive daily injections of lunasin, lunasin plus the chemotherapy drug oxaliplatin, oxaliplatin alone or neither compound. "The group that received lunasin alone had 50 percent fewer metastatic sites," reported Dr de Mejia. "But an even more exciting result was seen in the group that received both lunasin and the chemotherapy drug—only 5 new cancer sites when compared with 28 in the control group."

"This huge reduction in metastasis was achieved with the amount of lunasin in only 25 daily grams of soy protein, the amount recommended in the FDA health claim," noted Dr Dia, who is a University of Illinois postdoctoral fellow. "In this study, we have learned that lunasin can penetrate the cancer cell, cause cell death, and interact with at least one type of receptor in a cell that is ready to metastasize."

"Two glasses of soy milk a day generally provide half the amount of lunasin used in our study," Dr de Mejia remarked. "It certainly seems feasible to create a lunasin-enriched product that people could consume in a preventive way."

It's Not Too Late to Order the Gift of Health During Super Sale!

Super Sale:  Online Instant Savings!

Don't miss this opportunity to order gifts for your loved ones or something for yourself at the lowest prices you'll find this season. There's no better time to save than Super Sale. So call toll-free 1-800-544-4440 to order now!

Super Zeaxanthin with Lutein, Meso-Zeaxanthin Plus Astaxanthin and C3G
60 softgels
Item #01586

$42.00
$25.65*

ArthroMax™ Advanced with UC-II® & AprèsFlex™
60 capsules

Item #01618

$36.00
$21.60*

Bone Restore
150 capsules

Item #01611

$22.50
$13.16*

Calorie Control Weight Management Formula with CoffeeGenic™ Green Coffee Extract†
60 packets

Item #01694

$64.00
$40.50*

CoffeeGenic™ Green Coffee Extract
200 mg, 90 vegetarian capsules

Item #01604

$25.00
$14.85*

*Price based on 4-bottle Super Sale member purchase
†This supplement should be taken in conjunction with a healthy diet and regular exercise program. Results may vary.

http://www.lef.org/SuperSale/

Super Sale

Latest Supplements

Pharmocracy: How Corrupt Deals and Misguided Medical Regulations Are Bankrupting America—and What to Do About It, by William Faloon
Item #33835

add to cart

In a startling revelation, medical costs for a family of four will run $19,393 in the year 2011. That's an increase of $1,319 from 2010 and double what it cost in 2002. The obvious problem is that typical families cannot afford $19,393 yearly. Neither can their employers, their insurance companies, and certainly not our debt-laden state and federal governments.

There is a free market solution to today's artificially inflated health care costs. Congress can amend the law to allow free market forces to drive down sick care costs, better enable the prevention of diseases, and facilitate rapid development of improved medical therapies. A just-released book titled Pharmocracy provides factual documentation to reform the broken health care system that plagues the United States. It is more than 300 pages long because there are at least that many underlying reasons why medicine costs far more than it should.

Living Skin
4 ounces
Item #03188

add to cart

This skin care formulation designed by award-winning scientists Durk Pearson and Sandy Shaw for their own personal use in softening and smoothing fine lines, age spots, and imperfections, and for improving the look and feel of dry skin. The ingredients are a proprietary formulation of the finest alpha hydroxy acids (fruit acids), nutrient amino acids, vitamins, essential growth-regulating nutrients, free radical scavengers, moisturizers, penetration acids, skin protectants, and other beneficial skin care ingredients.

The faint aroma of baked bread and roses comes from functional ingredients; no perfume is added. You may apply to your neck, arms, elbows, hands, thighs, legs, knees, chest, stomach, back and buttocks. This product may be used under cosmetics.

shadow

Highlight

Life Extension Update What's Hot
Review finds dietary measures may aid in prostate cancer prevention and treatment Soy may help reduce prostate cancer risk
Genistein prevents prostate cancer metastasis in animal model Soy isoflavone intake associated with reduced prostate cancer incidence among Japanese
Pilot study finds soy lowers PSA without reducing testosterone Genistein reduces PSA in untreated prostate cancer
       
Life Extension Magazine® Health Topics
Is Soy Safe? Busting the Myths of a Nutritional Powerhouse Prostate Cancer / Prostate Health
Soy: A Promising Role in Cancer Prevention and Management Benign Prostatic Hyperplasia (BPH)
Soy & Cancer Prevention Complementary Alternative Cancer Therapies
       

shadow

UC-II® is a registered trademark of InterHealth Nutraceuticals, Inc. U.S. Patent Nos. 5,645,851, 5,637,321, 5,529,786, 5,750,144, 7,083,820, EP1485906 B1 and worldwide patents pending. AprèsFlex™ is a trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila Nutra LLC. International patents pending.